 |
 |
|
|
|
| Axitinib|319460-85-0 |
 |
| 99% |
 |
| 319460-85-0 |
 |
A kinase inhibitor, apply to a failure of previous systemic therapy of advanced renal cell carcinoma treatment.
|
 |
English name:2-(3-((E)-2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)-N-methylbenzamide
CAS NO.:319460-85-0
Appearance:white to light yellow solid powder
Purity(HPLC):>=99.5%
Usage:A kinase inhibitor, apply to a failure of previous systemic therapy of advanced renal cell carcinoma treatment.
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
